Premature ovarian failure

Obstetrics and Gynecology

Volumn 113, Issue 6, 2009, Pages 1355-1363

  Rebar, Robert W ^a,b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CALCIUM; CONJUGATED ESTROGEN; ESTRADIOL; ESTRONE; FOLLITROPIN; LUTEINIZING HORMONE; MEDROXYPROGESTERONE ACETATE; PROGESTERONE; VITAMIN D;

AMENORRHEA; ARTICLE; AUTOIMMUNE THYROIDITIS; CLINICAL FEATURE; CONCEPTION; DISEASE ASSOCIATION; ESTROGEN DEFICIENCY; FEMALE; FERTILIZATION IN VITRO; FMR1 GENE; GENE; GENE MUTATION; HORMONE SUBSTITUTION; HUMAN; HYPERGONADOTROPIC HYPOGONADISM; HYPOGONADISM; OOCYTE TRANSPORT; OSTEOLYSIS; OSTEOPENIA; OSTEOPOROSIS; OVULATION; PREGNANCY; PREMATURE OVARIAN FAILURE; PRIORITY JOURNAL; SYMPTOMATOLOGY; ADULT; REVIEW;

ADULT; FEMALE; HUMANS; OVARIAN FAILURE, PREMATURE; PREGNANCY;

EID: 67649395924     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e3181a66843     Document Type: Article

References (39)

1. Rebar RW, Erickson GF, Yen SS. Idiopathic premature ovarian failure: clinical and endocrine characteristics. Fertil Steril 1982;37:35-41.
2. de Moraes-Ruehsen M, Jones GS. Premature ovarian failure. Fertil Steril 1967;18:440-61.
3. Aiman J, Smentek C. Premature ovarian failure. Obstet Gynecol 1985;66:9-14.
4. Alper MM, Garner PR, Seibel MM. Premature ovarian failure. Current concepts. J Reprod Med 1986;31:699-708.
5. Coulam CB, Adamson SC, Annegers JF. Incidence of premature ovarian failure. Obstet Gynecol 1986;67:604-6.
6. Rebar RW, Connolly HV. Clinical features of young women with hypergonadotropic amenorrhea. Fertil Steril 1990;53: 804-10.
7. Nelson LM, Anasti JN, Kimzey LM, Defensor RA, Lipetz KJ, White BJ, et al. Development of luteinized graafian follicles in patients with karyotypically normal spontaneous premature ovarian failure. J Clin Endocrinol Metab 1994;79:1470-5.
8. Damewood MD, Grochow LB. Prospects for fertility after chemotherapy or radiation for neoplastic disease. Fertil Steril 1986;45:443-59.
9. Welt CK. Primary ovarian insufficiency a more accurate term for premature ovarian failure. Clin Endocrinol (Oxf) 2008;68: 499-509.
10. Nelson LM, Popat V. Ovarian insufficiency. eMedicine. Available from: http://www.emedicine.com/med/TOPIC3374.htm. Retrieved June 9, 2008.
11. Albright F, Smith PH, Fraser R. A syndrome characterized by primary ovarian insufficiency. Am J Med Sciences 1942;204: 625-48.
12. Rebar RW, Carter JM, Kim JG, Sites CK, Song DY, LaBarbera AR. Hypergonadotropic forms of amenorrhea. Randolf (MA): Serono Symposia; 1993. p. 275-93.
13. Rebar RW, Cedars MI. Hypergonadotropic amenorrhea. In: Filicori M, Flamigni C, editors. Ovulation induction: basic science and clinical advances. Amsterdam (Netherlands): Elsevier Science B.V.; 1994. p. 115-21.
14. Rebar RW. Primary hypogonadism in young women: socalled "premature ovarian failure." Menopause Manage 1995; 4:25-8.
15. Villanueva AL, Rebar RW. Triple-X syndrome and premature ovarian failure. Obstet Gynecol 1983;62:70s-3s.
16. Singh RP, Carr DH. The anatomy and histology of XO human embryos and fetuses. Anat Rec 1966;155:369-83.
17. Krauss CM, Turksoy RN, Atkins L, McLaughlin C, Brown LG, Page DC. Familial premature ovarian failure due to an interstitial deletion of the long arm of the X chromosome. N Engl J Med 1987;317:125-31.
18. Sherman SL. Premature ovarian failure in the fragile X syndrome. Am J Med Genet 2000;97:189-94.
19. LaBarbera AR, Miller MM, Ober C, Rebar RW. Autoimmune etiology in premature ovarian failure. Am J Reprod Immunol Microbiol 1988;16:115-22.
20. Lucky AW, Rebar RW, Blizzard RM, Goren EM. Pubertal progression in the presence of elevated serum gonadotropins in girls with multiple endocrine deficiencies. J Clin Endocrinol Metab 1977;45:673-8.
21. Jones GS, De Moraes-Ruehsen M. A new syndrome of amenorrhea in association with hypergonadotropism and apparently normal ovarian follicular apparatus. Am J Obstet Gynecol 1969;104:597-600.
22. Manuel M, Katayama PK, Jones HW Jr. The age of occurrence of gonadal tumors in intersex patients with a Y chromosome. Am J Obstet Gynecol 1976;124:293-300.
23. Portnoi MF, Aboura A, Tachdjian G, Bouchard P, Dewailly D, Bourcigaux N, et al. Molecular cytogenetic studies of Xq critical regions in premature ovarian failure patients. Hum Reprod 2006;21:2329-34.
24. Villanueva AL, Benirschke K, Campbell J, Wachtel SS, Rebar RW. Complete development of secondary sexual characteristics in a case of 46,XY gonadal dysgenesis. Obstet Gynecol 1984;64:68S-72S.
25. Wittenberger MD, Hagerman RJ, Sherman SL, McConkie- Rosell A, Welt CK, Rebar RW, et al. The FMR1 premutation and reproduction. Fertil Steril 2007;87:456-65.
26. Bakalov VK, Vanderhoof VH, Bondy CA, Nelson LM. Adrenal antibodies detect asymptomatic auto-immune adrenal insufficiency in young women with spontaneous premature ovarian failure. Hum Reprod 2002;17:2096-100.
27. Falorni A, Laureti S, Candeloro P, Perrino S, Coronella C, Bizzarro A, et al. Steroid-cell autoantibodies are preferentially expressed in women with premature ovarian failure who have adrenal autoimmunity. Fertil Steril 2002;78:270-9.
28. Alzubaidi NH, Chapin HL, Vanderhoof VH, Calis KA, Nelson LM. Meeting the needs of young women with secondary amenorrhea and spontaneous premature ovarian failure. Obstet Gynecol 2002;99:720-5.
29. van der Stege JG, Groen H, van Zadelhoff SJ, Lambalk CB, Braat DD, van Kasteren YM, et al. Decreased androgen concentrations and diminished general and sexual well-being in women with premature ovarian failure. Menopause 2008;15:23-31.
30. Kalantaridou SN, Vanderhoof VH, Calis KA, Corrigan EC, Troendle JF, Nelson LM. Sexual function in young women with spontaneous 46,XX primary ovarian insufficiency. Fertil Steril 2008;90:1805-11.
31. Rebar R. Premature ovarian failure. In: Lobo RA, editor. Treatment of the postmenopausal woman: basic and clinical aspects. 3rd ed. Oxford (UK): Academic Press; 2007. p. 99-109.
32. Chetkowski RJ, Meldrum DR, Steingold KA, Randle D, Lu JK, Eggena P, et al. Biologic effects of transdermal estradiol. N Engl J Med 1986;314:1615-20.
33. Hartmann BW, Kirchengast S, Albrecht A, Laml T, Söregi G, Huber JC. Androgen serum levels in women with premature ovarian failure compared to fertile and menopausal controls. Gynecol Obstet Invest 1997;44:127-31.
34. Elias AN, Pandian MR, Rojas FJ. Serum levels of androstenedione, testosterone and dehydroepiandrosterone sulfate in patients with premature ovarian failure compared to agematched menstruating controls. Gynecol Obstet Invest 1997; 43:47-8.
35. Chan CL, Cameron IT, Findlay JK, Healy D, Leeton JF, Lutjen PJ, et al., Oocyte donation and in vitro fertilization for hypergonadotropic hypogonadism: clinical state of the art. Obstet Gynecol Surv 1987;42:350-62.
36. Sauer MV, Paulson R. Oocyte donation for women who have ovarian failure. Contemp Obstet Gynecol 1989:125-35.
37. Rebar RW, Cedars MI. Hypergonadotropic forms of amenorrhea in young women. Endocrinol Metab Clin North Am 1992;21:173-91.
38. Karnis MF, Zimon AE, Lalwani SI, Timmreck LS, Klipstein S, Reindollar RH. Risk of death in pregnancy achieved through oocyte donation in patients with Turner syndrome: a national survey. Fertil Steril 2003;80:498-501.
39. Practice Committee, American Society for Reproductive Medicine. Increased maternal cardiovascular mortality associated with pregnancy in women with Turner syndrome. Fertil Steril 2005;83:1074-75.